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Abstract. The formal representation of clinical knowledge is still an open research topic. Classical representation
languages for clinical guidelines are used to produce diagnostic and treatment plans. However, they have important
limitations, e.g. when looking for ways to re-use, combine, and reason over existing clinical knowledge. These
limitations are especially problematic in the context of multimorbidity; patients that suffer from multiple diseases.
To overcome these limitations, this paper proposes a model for clinical guidelines (TMR4I) that allows the re-use
and combination of knowledge from multiple guidelines. Semantic Web technology is applied to implement the
model, allowing us to automatically infer interactions between recommendations, such as recommending the same
drug more than once. It relies on an existing Linked Data set, DrugBank, for identifying drug-drug interactions. We
evaluate the model by applying it to two realistic case studies on multimorbidity that combine guidelines for two
(Duodenal Ulcer and Transient Ischemic Attack) and three diseases (Osteoarthritis, Hypertension and Diabetes)
and compare the results with existing methods.
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1. Introduction
Information and communication technologies
are widely adopted in the clinical domain as
Healthcare Information Systems. The primary foci
of these systems are data management and vi-
sualization. Because of this, there is an increas-
ing amount of patient data that can be used to
study disease behavior and the effectiveness of cer-
tain treatments. The outcomes of such studies find
their way into so-called “reference documents” for
clinical practices, promoting the use of evidence-
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based medicine (EBM). Clinical guidelines (CGs)
accumulate and reflect knowledge on how to best
diagnose and treat diseases in the form of a list of
recommendations. Guidelines have a formal status;
they are sanctioned by national and international
health care organizations. Relatively recently, the
reference documents of EBM have started to be re-
grouped and published as CGs in their own right:
evidence-based guidelines.
In the last decades, Computer Interpretable
Guidelines (CIGs) emerged as formal representa-
tions of CGs. They can have distinct benefits over
paper-based CGs in that they increase flexibility,
minimize errors, and generalize the use of guide-
lines across institutions. CIGs are expressed in
dedicated languages such as GLIF [2], Asbru [16]
or PROforma [24]. They are mainly designed to
promote the execution of guidelines, i.e. to apply
them to patient data for supporting diagnostics
or treatment plans. Hereafter we refer to CIGs as
guidelines and to CGs as paper-based guidelines.
By definition, CGs address specific clinical sit-
uations, i.e. situations around a single disease.
Following the same principle, guideline languages
were defined to represent (and execute) one CG
per time. They are not flexible enough to support
cases where (parts of) multiple guidelines need to
be combined. This is most problematic in the case
of multimorbidity; situations where a patient suf-
fers from multiple diseases at the same time. With
demographic changes related to aging, and the in-
crease of chronic diseases, multimorbidity is be-
coming more frequent. A Dutch study shows that
not only the number of chronic diseases doubled
in twenty years (1985-2005), the proportion of pa-
tients with four or more chronic diseases tripled
in the same period [25]. Applying CGs for dif-
ferent diseases independently may lead to con-
flicting situations that can be detrimental to the
health condition of the patient. For instance, As-
pirin is recommended as anti-platelets to patients
diagnosed with Transient Ischemic Attack. On the
other hand, Aspirin is not recommended for Duo-
denal Ulcer patients because it increases the risk
of bleeding.
A solution for this problem is considered as an
important challenge for clinical decision support
systems [23]. Some existing approaches for CIGs
are unable to automatically detect conflicts for
combinations of guidelines [11,14]. They also can-
not propose alternative measures that would re-
solve the conflicts. Other approaches [26] require
all the possible conflicts and their solutions to be
available in a knowledge base. In general, the stud-
ied approaches do not properly address the com-
bination of more than two guidelines.
In earlier work [30], we introduced the Transition-
based Medical Recommendations (TMR) model;
a conceptual model that uses the concepts of rec-
ommendation, transition, care action type and sit-
uation type to represent clinical guidelines in a
more flexible and expressive way. We had selected
a set of common conflicting situation to evaluate
the capability of detecting and solving of several
approaches and identify the opportunities to com-
plement them.
The goal of the work presented in this paper
is to pave the way towards an automatic identi-
fication of common potential conflicts or interac-
tions that can happen when merging guidelines.
We address the interactions that can be tackled
independently of particular contexts of patients,
taking into account the general context described
in the guidelines and eventually complemented by
Medical Background Knowledge (MBK) (Section
1 paragraph 6). This paper extends TMR to al-
low for the automatic inference of interactions be-
tween recommendations (TMR4I). The model al-
lows us to classify different types of interactions
(conflicts, duplicates, repetitions), and show possi-
ble alternative solutions. We implement the mod-
els using OWL, SWRL and SPARQL, and build
a web application that allows for (semi)automatic
detection of internal and external interactions be-
tween recommendations. This allows us to detect
cases that require special attention from experts
when two or more guidelines are combined for a
multimorbidity patient; and provide suggestions
for improvements.
The use of Semantic Web representation lan-
guages allows us not only to infer and detect these
issues, they also allow us to tap into the enor-
mous amount of relevant clinical information pub-
lished as Linked Data, e.g. biomedical terminolo-
gies, drug databases, symptoms and side effect
databases.
We evaluate TMR4I by applying it to two case
studies of combined guidelines taken from alter-
native approaches in the literature [26,11,14]. The
first is a merge of two guidelines, one on Duodenal
Ulcer (DU) and the other on Transient Ischemic
Attack (TIA). The second merges three guidelines
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on Osteoarthritis (OA), Hypertension (HT) and
Diabetes (DB). These use cases also featured in
our earlier work [30,31]. We show the added value
of our model by comparing it to the existing ap-
proaches described in [26,11,14].
The contributions of this paper are:
– A formal representation of TMR4I, an exten-
sion of TMR [30] that allows for the detection
of interactions between recommendations in
multiple clinical guidelines.
– Definition of “guideline-independent” rules
for detecting internal and external interac-
tions that allows for a more reusable and scal-
able approach in the sense of number of in-
teractions that can be semi-automatically de-
tected and number of guidelines that can be
combined.
– An implementation of TMR4I using Seman-
tic Web languages (OWL, SWRL, SPARQL)
that integrates with external knowledge from
the Linked Data cloud (the Linked Data ver-
sion of DrugBank [28,12]).
– A web application that allows for brows-
ing (combined) guidelines and informs users
about inferred interactions between recom-
mendations, the type and source of each in-
teraction, and offers potential solutions.
– An evaluation of the approach for two use
cases, that compares the TMR4I model with
existing approaches that target the same com-
bination of guidelines [26,11,14].
This paper is structured as follows: Section 2
discusses related work. Section 3 introduces some
preliminaries, including the concepts of the TMR
model that underly TMR4I. Section 4 presents the
TMR4I extension of TMR as a formal model. Sec-
tion 5 describes our case studies for multimorbid-
ity. Section 6 and 7 present respectively the imple-
mentation and the obtained results. Finally, Sec-
tion 8 discusses the results and outlines future
work and Section 9 summarizes this work.
2. Related Work
This section presents works related to Computer-
based Representations of Clinical Guidelines in
general, and Semantic Web-based ones in particu-
lar. Moreover, we present approaches for address-
ing multimorbidity and clinical knowledge avail-
able on the Semantic Web.
2.1. Computer-Interpretable Clinical Guidelines
Several guideline description languages exist
that are aimed at representing clinical knowledge:
PROforma [24], GLIF [2], Asbru [16], etc. The
main focus of these languages is on guideline exe-
cution, which makes them highly procedural and
targeted to modeling a specific case. They are lim-
ited with respect to interoperability (guidelines
cannot be combined), semantics (free text is of-
ten used to describe conditions and actions) and
reasoning power (e.g. the inference of interactions
and their solutions is not supported) [9,18].
At the same time clinical decision support sys-
tems (CDSS) fall short in assisting healthcare pro-
fessionals in defining treatment plans for multi-
morbid patients [3]. There is a “lack of provision of
integrated medical guidelines for multiple chronic
diseases within current CDSS” [3]. Combined with
the inflexibility of existing CIG languages, this in-
dicates the necessity for new, more powerful and
flexible formalisms or for adapting existing ones.
2.2. Semantic Web-based Guideline
Representations
Semantic Web technologies have already been
investigated for the representation of guidelines.
In particular, OWL ontologies were used to en-
hance the representation of clinical knowledge of
guidelines making it more comprehensible for com-
puters. For instance, Pruski et al. [21] focused on
the description of care actions usually expressed in
natural language to better personalize treatment
plans. Peleg et al. [17] proposed to reason with
guideline action effects using OWL and abduc-
tion. Abidi et al. [1] introduced the COMET (Co-
morbidity Ontological Modeling & ExecuTion)
system that provides decision support to handle
co-morbid chronic heart failure and a trial fibril-
lation. This framework relies on the capabilities
of ontologies to represent guideline content and
semantic alignment techniques to merge clinical
pathways. The work of Isern et al. [10] stresses the
use of ontologies to enable the execution of guide-
lines tailored to a well-identified clinical environ-
ment. In [29], Yao et al. derive SWRL rules from
guidelines to dynamically adapt clinical pathways,
represented in BPMN, according to clinical ac-
tivities (contextual data and procedure actions).
Hoekstra et al. [7] propose a lightweight ontology
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for annotating evidence-based clinical guidelines
(adopting the W3C PROV and biomedical-related
vocabularies), connecting recommendations to un-
derlying evidence, and representing recommenda-
tions strength and evidence quality.
Still, these approaches are not designed for ad-
dressing multimorbidity. In this work we propose
to use the Semantic Web for representing guide-
line content to enhance the reasoning capabilities
of computer systems; allowing a better detection
of interactions between guidelines in case of co-
morbid patients. Secondly, it facilitates the inte-
gration of external knowledge sources expressed in
RDF. This allows us to reuse clinical knowledge;
thereby, in the end, improving the quality of med-
ical decisions.
2.3. Multimorbidity
In [30], we reviewed existing approaches for
merging treatments plans or guidelines and we
categorized them into: (i) guideline-level verifica-
tion, (ii) on-prescription verification, (iii) after-
prescription verification and (iv) on-treatment-
execution verification. As re-usability is one of our
major concerns, in this section we discuss three
approaches in the first level [26,11,14].
Constraint Logic Programming Wilk et al. [26]
describe guidelines as an activity graph. They use
constraint logic programming (CLP) to identify
conflicts that result from applying two CGs to the
same patient and propose mitigation alternatives.
The temporal aspect is not considered, thus the
approach can only be applied to specific situa-
tions (e.g. acute diseases diagnosed during a single
patient-physician encounter). This approach also
considers that all predicates use the same termi-
nology and that they can have only two states
(true or false). Although their approach allows the
conflicts and solutions to be automatically iden-
tified, it relies on the availability of knowledge
bases associated with each guideline. It means
that both conflicts and solutions need to be previ-
ously defined in a Medical Background Knowledge
(MBK) as guideline-dependent rules/constraints.
Moreover, the solutions proposed to the conflicts
are introduced using the same formalism of the
original recommendations, which means that their
approach would still be applicable to the resultant
guideline (merge plus extra recommendations) in
order to verify eventual new conflicts. However,
they do not perform such verification to the pro-
posed case study. Indeed, a considerable limitation
for allowing this feature is that detecting new con-
flicts would require the introduction of new rules/-
constraints in the MBK. Finally, automatically re-
trieving clinical knowledge from existent reposito-
ries such as drug-drug and drug-disease interac-
tions, as well as combining more than two guide-
lines are proposed as future work both in [26,27].
However, to the best of our knowledge these fea-
tures were not yet addressed.
OntoMorph The OntoMorph approach by Jafar-
pour [11] defines a set of ontologies to represent:
the guidelines (LKO - local knowledge ontology),
the general domain (DKO - domain knowledge on-
tology), the mappings between LKO and DKO
(KMO - knowledge mappings ontology), and the
decision rules for concurrent execution of LKO,
provided by domain experts (KPO - knowledge
morphing ontology). The ultimate objective is to
define a framework that can be used to merge
heterogeneous knowledge from the same domain.
However, using several ontologies can potentially
rise some extra challenges, like decidability (hav-
ing rules for all decision cases), maintenance (man-
aging the consequences of changing the ontolo-
gies or mappings), and consistency (verifying con-
tradictions between local or domain rules). This
situation requires a laborious work from domain
experts to map LKO to DKO following a rig-
orous and unambiguous process (all LKOs must
be mapped in the exact same way). These ex-
perts are also required to identify all possible in-
teractions between LKOs and to provide the cor-
respondent consistent decision rules as solutions
to the conflicts. Although these rules are neces-
sary to generate conflict-free guidelines, they must
be general enough to be applied to all combina-
tions of LKOs. Some situations are hardly pre-
dictable, for instance, pairwise analysis of rec-
ommendations from guidelines will not allow de-
tecting overdose of medication if it comes from
the associations of three or more recommenda-
tions. Another challenge from this approach comes
from the ontology alignment technique. The es-
tablishment of semantic relations (mappings) be-
tween heterogeneous data can require many com-
plex techniques, for instance, natural language
processing techniques would be necessary if tex-
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tual information are provided describe concepts
of the LKO (e.g. in one LKO there are the
blood pressure "higvalue:120", "lowvalue:80" and
"unity:mmHg", while in the other LKO there is
"value: 120/80mmHg").
Jafarpour uses OWL and SWRL to represent
and merge the guidelines. The latter defines Con-
straints (rules) as entities that relates pairs of in-
teracting Tasks (actions). These manually created
rules are supposed to address cases where tasks
(a) are identical, (b) should be executed simul-
taneously, (c) are conflicting, (d) can reuse each
other‘s results, (e) have a temporal or sequential
constraint between them, (f) can be combined to a
new task and (g) their execution schedule depends
on operational constraints for their simultaneous
execution.
Rule-Based Combinations Lopez-Vallverdu et al.
[14] focus on Rules and Actions concerned with
the administration of drugs. They use a standard
terminology called ATC (Anatomical Therapeu-
tic Chemical Classification System for drugs1).
Based on knowledge available in clinical guide-
lines, they manually built “knowledge units” for
pairwise combination of three diseases: Hyperten-
sion, Diabetes Mellitus and Heart Failure. Knowl-
edge units can be about the co-existence of in-
compatible drugs (drug-drug interaction), the ex-
istence of a drug incompatible to a disease (drug-
disease interaction) and the absence of a drug nec-
essary for a combination of diseases. Based on
these units, they manually built a minimal set of
combination rules in the format pre-condition :
condition → action. The pre-condition is a dis-
ease, the condition is the presence or absence of
drug recommendations for each disease, and the
action holds recommendations for adding, remov-
ing or replacing drugs. Although it is not clear
from the knowledge format whether it is limited
to two diseases, the strategy adopted by the au-
thors for addressing the three aforementioned dis-
eases is by pairwise combining them. Moreover,
the manual identification of the interactions and
their solutions is in itself a limiting factor for com-
bining multiple guidelines. Their approach is im-
plemented in a proprietary system for combining
treatments.
1http://www.whocc.no/atc/
In summary, these approaches are not suffi-
cient to meet the objective of increasing the abil-
ity to handle multimorbidity, since they have im-
portant limitations such as manual definition of
guideline-dependent rules/constraints for pairwise
detecting conflicts. Therefore, we pursue an ap-
proach that allows us to evaluate a set of rec-
ommendations, originating from multiple guide-
lines, inferring and identifying the types of inter-
actions amongst them; with minimal human inter-
action. In this context, the reuse of existing medi-
cal sources such as available in Linked Data is very
attractive.
2.4. Ontologies and Linked Data
Since one of the long term goals of our work
is to provide means to completely describe care
actions in a computer-interpretable formalism, a
primary problem to be considered is how to as-
sure the normalization of the terminologies used
to describe the actions and conditions. If a wide
use of formalized care actions is expected, then
their description need to be based on standard ter-
minologies with an explicit semantic behind. Sev-
eral standard terminologies exist (e.g. SNOMED-
CT2, ATC, etc.) which can be used to describe
care actions and conditions. In our approach, we
assume that instances of the TMR model will be
created based on existing standard terminologies
or, when necessary, based on other publicly avail-
able Ontologies from the biomedical domain. For
instance, one of the ∼ 390 ontologies (∼ 5 mil-
lions classes) published in BioPortal [40] or acces-
sible via EHTOP [4]. Another assumption of our
approach is that care action descriptions refer to
the source of information that generates the re-
lated evidence. For instance, one transition can
be associated to evidence from clinical trials (e.g.
those published in [41]) which details the condi-
tions where it was observed. The potential of Se-
mantic Web technologies for making clinical guide-
lines and protocols more flexible is also recognised
in [22]. Since a lot of life science information is
available as Linked Data, it becomes an important
resource for improving the quality of information
generated by clinical decision support systems. Ac-
cording to Mannheim Linked Data Catalog [33]
2http://www.ihtsdo.org/snomed-ct
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there are 85 datasets built based on Semantic Web
technologies that can be used to provide large net-
works of Linked Data for the Life Science domain.
Some platforms were created to regroup datasets
and provide an unified way to query across re-
sources using the W3C SPARQL query language
(e.g. Bio2RDF [34] with more that ∼11 Billion
RDF triples available and EBI-RDF [13]). In this
work we selected one dataset relevant to evaluate
the proposed approach: DrugBank [35,28,12] (∼3
milions RDF triples), but our approach is generic
enough to use more datasets (e.g. Drugbank +
Sider [38] (∼17 millions RDF triples), Clinical tri-
als [37] (+25 milions RDF triples), Diseasome [36]
(+9K RDF triples), etc.).
3. Overview of the TMR Model
This section briefly summarizes a slightly ex-
tended version of the TMR model, originally pre-
sented in [30] where we investigated the core con-
cepts required for representing recommendations
within CGs. Figure 1 shows a UML diagram of the
TMR model. The concepts and relations presented
as they were in the original version are depicted in
gray shade to differ from the new concepts and re-
lations changed or introduced in this work. Those
that have a slash sign before their names are fur-
ther defined by FOL (First Order Logics) formu-
las (e.g. /similarTo). We consider the concepts as
being atomic, since its compositionality is out of
scope of this work.
– A Guideline is an aggregation of Recommendations,
whilst the latter is part of one Guideline. It can be
a Single Disease Guideline, or it can be a Composed
Guideline, which is derived from the combination of
two or more Guidelines.
– A Recommendation either recommends to pursue or
recommends to avoid (originally recommends and non-
recommends) one Transition.
– A Transition is promoted by a single Care Action Type,
which in turn can promote one or more Transitions.
A Transition can be similar to or inverse to another
one (definition is further provided).
– Situation Types can be Pre or Post-Situation Types in
the context of different Transitions.
– Every Transition have:
∗ one Transformable Situation Type through the rela-
tion has transformable situation,
∗ one expected Post-Situation Type through the re-
lation has expected post situation, and
∗ zero or more Non-Transformable Situation Types
through the relation have as filter condition.
For example, Table 1 presents the recommen-
dation “If the patient’s temperature is over 37 de-
grees and he/she is over 10 years old then reduce
the temperature by administering aspirin” decom-
posed into the TMR concepts.
We introduce the binary relations /similarTo
and /inverseTo between Transitions, which are re-
quired for detecting Interactions. In this work we
consider a simple approach of comparing equal-
ity among Pre and Post-Situation Types, though
these definitions would benefit from a richer def-
inition of Situation Types and possible matches
among them. Therefore, similar transitions (def.
1.1) are those whose Pre-Situation Types are the
same, as well as the Post-Situation Types, but that
are promoted by different Care Action Types (oth-
erwise they are the same transition). Two tran-
sitions are inverse (def. 2.1) if the Pre-Situation
Type of one is equal to the Post-Situation Type of
the other. Both relations similarTo and inverseTo
are symmetric (def. 1.2 and 2.2).
(1.1) ∀t1, t2, sa, sb, ca1, ca2( Transition(t1)
∧ Transition(t2) ∧ CareActionType(ca1)
∧ CareActionType(ca2) ∧ promotedBy(t1,ca1)
∧ promotedBy(t2,ca2) ∧ ca1 6= ca2
∧ SituationType(sa) ∧ SituationType(sb)
∧ hasTransformableSituation(t1,sa)
∧ hasTransformableSituation(t2,sa)
∧ hasExpectedSituation(t1,sb)
∧ hasExpectedSituation(t2,sb) )
↔ similarTo(t1,t2)
(1.2) ∀t1, t2 similarTo(t1,t2) ↔ similarTo(t2,t1)
(2.1) ∀t1, t2, sa, sb( Transition(t1) ∧ Transition(t2)
∧ SituationType(sa) ∧ SituationType(sb)
∧ hasTransformableSituation(t1,sa)
∧ hasTransformableSituation(t2,sb)
∧ hasExpectedSituation(t1,sb)
∧ hasExpectedSituation(t2,sa) )
↔ inverseTo(t1,t2)
(2.2) ∀t1, t2 inverseTo(t1,t2) ↔ inverseTo(t2,t1)
In [30] we illustrated the applicability of TMR
by describing the possible interactions among rec-
ommendations. These interactions can be contra-
dictory, optimizable or reflect alternative recom-
mendations (redefined in Sect. 4). We advocated
that the TMR concepts favor the detection of such
interactions, which may require some attention
from experts when combining CGs due to comor-
bidity. Moreover, we considered not all interac-
tions are unwelcome (e.g. the recommendations to
inverse transitions may be desirable and the alter-
native ones are useful to avoid conflicts) although
they could still require attention (e.g. defining
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Fig. 1. UML class diagram for the TMR Model.
Table 1
TMR Concepts Summary.
Situation Type Represents a property and its admissible values
Transformable
Situation Type
Regards the situation that is expected to be changed Patient’s temperature is over 37 degrees
Non-
Transformable
Situation Type
Regards the situation that holds as filter condition Patient’s age is over 10 years old
Post-Situation
Type
Regards the situation that is expected to be achieved Patient’s temperature is below 37 degrees
Care Action Type Represents the action types that can be performed by
health care agents in order to change a situation.
Administer aspirin
Transition Represents the possibility of changing a situation
regarding a patient by performing a care action type.
Administering aspirin in patient over 10 years
old reduces its temperature below 37 degrees
Recommendation Represents a suggestion to either pursue or avoid a
transition promoted by a care action type.
which alternative recommendation is preferred).
In the following section we extend the TMR model
for the specific task of representing and detecting
interactions among recommendations.
4. The TMR4I Model
The TMR4I (Transition-based Medical Recom-
mendations for [detecting] Interactions) model is
meant for detecting interactions among recom-
mendations when addressing multimobidity. In
this case more than one disease, originally ad-
dressed in different guidelines, need to be taken
into account. Therefore, the recommendations
combined from the different guidelines may inter-
act, e.g. presenting inconsistencies or being suscep-
tible to optimization. The main concept in TMR4I
is the interaction, which can be internal, among
the recommendations themselves, or with some ex-
ternal knowledge base holding e.g. clinical knowl-
edge (e.g. overdose). In Sect. 4.1 we focus on the
internal interactions whilst the external ones are
addressed in Sect. 4.2. Moreover, since the tempo-
ral/sequence aspects are still not addressed in this
work, the interactions here defined are considered
either time-independent or simultaneous.
4.1. Internal Interactions
Figure 2 illustrates in a graphical notation the
TMR4I representation for the examples discussed
in Table 2. Arrows connecting Recommendations
(on the left hand side) to Transitions (on the right
hand side) mean that the former recommends the
latter to be pursued or avoided. The blue arrow
labeled “do” means the transition is to be pur-
sued, while the red one labeled “do not” means the
opposite. Each transition regards a property (e.g.
gastrointestinal bleeding) and the pre and post sit-
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Table 2
Interactions Summary.
Contradiction Interactions two recommendations that would lead to a conflict if recommended
together (i.e. they cannot be both followed at the same time)
Opposed recommendations to the same care
action
- Do not administer aspirin to avoid increasing the risk of gastrointestinal
bleeding
- Administer aspirin to handle inflammation
Opposed recommendations to similar
transitions
- Do not adm. beta-blockers to avoid lowering blood pressure
- Administer ACE inhibitor to lower blood pressure
Recommendations to inverse transitions - Administer ACE inhibitor to lower blood pressure
- Administer midodrine to increase blood pressure
Repetition Interactions set of recommendations that are susceptible to optimization
Repeated recommendations to the same care
action
- Administer aspirin to reduce the risk of thrombus
- Administer aspirin to relief pain
- Administer aspirin to handle inflammation
Alternative Interactions set of recommendations that hold as alternatives.
Repeated recommendations to the similar
transitions promoted by different care action
- Administer aspirin to handle inflammation
- Administer ibuprofen to handle inflammation
- Administer naproxen to handle inflammation
Non-recommended transition whose inverse
transition is recommended
- Do not administer aspirin to avoid increasing the risk of gastrointestinal
bleeding
- Adm PPI to decrease risk of gastrointestinal bleeding
uations are presented as small boxes connected by
an arrow, where the box in the left hand side is
the transformable pre-stituation and the other one
is the expected post-situation. If there is a dot-
ted box in the left hand side, it represents a filter
condition (non-transformable situation). Finally, a
dotted ellipse on the arrow represents the care ac-
tion type that could promote the transition. We
depict the interactions named by their three main
types (Repetition, Contradiction and Alternative)
connecting the interacting recommendations. For
example, the third interaction (from top to bot-
tom) is a Repetition Interaction among three rec-
ommendations for different Transitions promoted
by Administer Aspirin.
Figure 3 presents an UML class diagram for the
TMR4I model. Elements presented in a gray-shade
mean they were previously introduced. The con-
cept Recommendation is specialized into /Inter-
nally Interacting Recommendation (def. 3) to de-
note the ones that internally interacts with other
recommendations.
(3) ∀r, ∃i( Recommendation(r)
∧ InternalRecommendationInteraction(i) ∧ relates(i,r) )
↔ InternallyInteractingRecommendation(r)
The interaction relation is reified as /Internal
Recommendation Interaction and /relates two or
more Recommendations in the context of a Guide-
line. The latter concept is specialized according to
the classifications discussed in Table 2. They are
further described and defined according FOL rules
(def. 4 to 9). In particular some interaction types
need an extra rule to capture their cumulative be-
haviour. For example, recommending 4 times Ad-
minister Aspirin for different purposes should not
be considered as 6 different interactions between
each pair of recommendations, but one interaction
among 4 recommendations.
Repetition due to Same Action: when Transi-
tions promoted by a same Care Action Type are
recommended to be pursued (def. 4.1). This inter-
action is cumulative within a (merged) guideline,
i.e. if a recommendation is related to two interac-
tions of this type, they are the same interaction
(def. 4.2)
(4.1) ∀g, r1, r2, t1, t2, ca( Guideline(g) ∧ Recommendation(r1)
∧ Recommendation(r2) ∧ partOf(r1,g) ∧ partOf(r2,g)
∧ Transition(t1) ∧ Transition(t2) ∧ r1 6= r2
∧ recommendsToPursue(r1,t1)
∧ recommendsToPursue(r2,t2) ∧ CareActionType(ca)
∧ promotedBy(t1,ca) ∧ promotedBy(t2,ca) )
→ ∃i( RepetitionDueToSameAction(i) ∧ relates(i,r1)
∧ relates(i,r2) )
(4.2) ∀i1, i2, r1, r2, r3( RepetitionDueToSameAction(i1)
∧ RepetitionDueToSameAction(i2) ∧ Recommendation(r1)
∧ Recommendation(r2) ∧ Recommendation(r3) ∧
r1 6= r3
∧ r1 6= r2 ∧ r2 6= r3 ∧ relates(i1,r1)
∧ relates(i1,r2) ∧ relates(i2,r2) ∧ relates(i2,r3) )
→ i1 = i2
Contradiction Interaction due to Inverse Transi-
tions: when two inverse Transitions are (simulta-
neously) recommended to be pursued (def. 5);
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Recommendations
Gastrointestinal Bleeding
high 
risk
Administer
Aspirin
low
risk
Avoid Bleeding do not
Blood Pressure
lowAdminister Beta-blockersnormal
Avoid Low 
Blood Pressure do not
Pain
no painAdminister Aspirinpain
Reduce Pain do
Blood Pressure
lowAdminister ACE inhibitornormal
Reduce 
Blood Pressure do
Transitions by Care Actions
Avoid Thrombi do
Risk of Thrombus
low riskAdminister Aspirin
medium 
risk
Protect 
Duodenum do
Gastrointestinal Bleeding
high 
risk
low 
risk
Administer 
PPI
contradiction
Inflammation
healedAdminister Aspirinunhealed
Heal 
Inflammation do
Inflammation
healedAdminister Ibuprofenunhealed
Heal 
Inflammation do
Inflammation
healedAdminister Naproxenunhealed
Heal 
Inflammation do
Blood Pressure
normalAdminister Midodrinelow
Increase 
Blood Pressure do
alternative
contradiction
contradiction
alternative
repetition
Fig. 2. Instance-schema for illustrating interactions among
recommendations.
(5) ∀g, r1, r2, t1, t2( Guideline(g) ∧ Recommendation(r1)
∧ Recommendation(r2) ∧ partOf(r1,g) ∧ partOf(r2,g)
∧ Transition(t1) ∧ recommendstoPursue(r1,t1)
∧ Transition(t2) ∧ recommendstoPursue(r2,t2)
∧ inverseTo(t1, t2) )
→ ∃i( ContradictionDueToInverseTransition(i)
∧ relates(i,r1) ∧ relates(i,r2) )
Contradiction Interaction due to Same Action:
when two Transitions promoted by the same Care
Actions Type are recommended to be pursued and
the other recommended to be avoided (def. 6);
(6) ∀g, r1, r2, t1, t2, ca( Guideline(g) ∧ Recommendation(r1)
∧ Recommendation(r2) ∧ partOf(r1,g) ∧ partOf(r2,g)
∧ r1 6= r2 ∧ Transition(t1) ∧ Transition(t2)
∧ recommendsToPursue(r1,t1) ∧ promotedBy(t1,ca)
∧ recommendsToAvoid(r2,t2) ∧ promotedBy(t2,ca)
∧ CareActionType(ca) )
→ ∃i( ContradictionDueToSameAction(i) ∧ relates(i,r1)
∧ relates(i,r2) )
Contradiction Interaction due to similar Transi-
tions: when two similar Transitions are one recom-
mended to be pursued and the other recommended
to be avoided (def. 7);
(7) ∀g, r1, r2, t1, t2( Guideline(g) ∧ Recommendation(r1)
∧ Recommendation(r2) ∧ partOf(r1,g) ∧ partOf(r2,g)
∧ Transition(t1) ∧ Transition(t2) ∧ similarTo(t1, t2)
∧ recommendsToPursue(r1,t1)
∧ recommendsToAvoid(r2,t2) )
→ ∃i( ContradictionDueToSimilarTransition(i)
∧ relates(i,r1) ∧ relates(i,r2) )
Alternative Interaction due to similar Transitions:
when similar Transitions are recommended to be
pursued (def. 8.1). This interaction is cumulative
within a (merged) guideline, i.e. if a recommen-
dation is related to two interactions of this type,
they are the same interaction (def. 8.2)
(8.1) ∀g, r1, r2, t1, t2( Guideline(g) ∧ Recommendation(r1)
∧ Recommendation(r2) ∧ partOf(r1,g) ∧ partOf(r2,g)
∧ Transition(t1) ∧ Transition(t2) ∧ similarTo(t1, t2)
∧ recommendsToPursue(r1,t1)
∧ recommendsToPursue(r2,t2) )
→ ∃i( AlternativeDueToSimilarTransition(i)
∧ relates(i,r1) ∧ relates(i,r2) )
(8.2) ∀i1, i2, r1, r2, r3( AlternativeDueToSimilarTransition(i1)
∧ AlternativeDueToSimilarTransition(i2)
∧ Recommendation(r1) ∧ Recommendation(r2)
∧ Recommendation(r3) ∧ r1 6= r3 ∧ r1 6= r2
∧ r2 6= r3 ∧ relates(i1,r1) ∧ relates(i1,r2)
∧ relates(i2,r2) ∧ relates(i2,r3) )
→ i1 = i2
Alternative Interaction due to Inverse Transi-
tion: when two inverse Transitions are one recom-
mended to be pursued and the other recommended
to be avoided (def. 9);
(9) ∀g, r1, r2, t1, t2( Guideline(g) ∧ Recommendation(r1)
∧ Recommendation(r2) ∧ partOf(r1,g) ∧ partOf(r2,g)
∧ Transition(t1) ∧ Transition(t2) ∧ inverseTo(t1, t2)
∧ recommendsToPursue(r1,t1)
∧ recommendsToAvoid(r2,t2) )
→ ∃i( AlternativeDueToInverseTransition(i)
∧ relates(i,r1) ∧ relates(i,r2) )
4.2. External Interactions
In this paper we address two types of Exter-
nal Interactions based on the following informa-
tion about Drug (types): (i) drugs that are known
to be incompatible to each other (e.g. Aspirin is
incompatible with Ibuprofen) and (ii) drug (types)
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Fig. 3. UML class diagram for the TMR4I Model- Internal Interactions.
that are grouped in a broader type/category ac-
cording to the effects they are expected to promote
(Aspirin and Tramadol (types) are grouped/sub-
ssumed by Anti-platelets Type/Category).
Figure 4 presents an UML class diagram for
the fragment of TMR4I model regarding External
Interactions. Elements presented in a gray-shade
mean they were previously introduced. The con-
cept Recommendation is specialized into /Exter-
nally Interacting Recommendation (def. 10) to de-
note the ones that interacts with external infor-
mation and/or other recommendations.
(10) ∀r, ∃i( Recommendation(r) ∧
ExternalRecommendationInteraction(i) ∧ relates(i,r) )
↔ ExternallyInteractingRecommendation(r)
The external interaction relation is reified as
/External Recommendation Interaction and /re-
lates one or more Recommendations of a Guideline
with External Information. The two types of ex-
ternal interaction aforementioned are represented
as Incompatible Drug Interaction and Alternative
Drug Interaction. They are further described and
defined according FOL rules (def. 11 and 12). Fi-
nally a Transition or a Care Action Type may
regard an External Information. In particular A
care action type may involve an External Drug
Type (e.g. Administer Aspirin involves Aspirin)
and a Transition may regard an External Drug
Type (e.g. Reduce Pain regards Painkiller).
Incompatible Drug Interaction: when two rec-
ommended (to be pursued) actions are associ-
ated with external information about incompati-
ble drugs (def. 11);
(11) ∀g, r1, r2, t1, t2, ca1, ca2, d1, d2( Guideline(g)
∧ Recommendation(r1) ∧ Recommendation(r2)
∧ partOf(r1,g) ∧ partOf(r2,g) ∧ r1 6= r2
∧ Transition(t1) ∧ recommendsToPursue(r1,t1)
∧ Transition(t2) ∧ recommendsToPursue(r2,t2)
∧ CareActionType(ca1) ∧ CareActionType(ca2)
∧ promotedBy(t1, ca1) ∧ promotedBy(t2, ca2)
∧ ExternalDrugType(d1) ∧ ExternalDrugType(d2)
∧ regards(ca1, d1) ∧ regards(ca2, d2)
∧ incompatibleWith(d1, d2) )
→ ∃i( IncompatibleDrugInteraction(i) ∧ relates(i,r1)
∧ relates(i,r2) ∧ relates(i,d1) ∧ relates(i,d2) )
Alternative Drug Interaction: when a recommen-
dation for administering a drug have a contradic-
tory or a incompatible-drug interaction, and the
transition is associated with external information
about the drug category corresponding to the ex-
pected effect of the action, then other drugs be-
longing to the same drug category can be sug-
gested as alternatives, once they are not incom-
patible with other recommended drugs (def. 12);
(12.1) ∀g, r1, i1, t1, ca1, d1, dc, d− alt( Guideline(g)
∧ Recommendation(r1) ∧ partOf(r1,g) ∧ relates(i1,r1)
∧ (ContradictionDueToSameAction(i1)
∨ ContradictionDueToSimiliarTransition(i1)
∨ ContradictionDueToInverseTransition(i1)
∨ IncompatibleDrugInteraction(i1))
∧ Transition(t1) ∧ recommendsToPursue(r1,t1)
∧ CareActionType(ca1) ∧ promotedBy(t1,ca1)
∧ ExternalDrugType(d1) ∧ regards(ca1,d1)
∧ ExternalDrugType(dc) ∧ regards(t1,dc)
∧ subssumes(dc,d-alt)
∧¬∃r2, t2, ca2, d2( Recommendation(r2) ∧ partOf(r2,g)
∧ Transition(t2) ∧ recommendsToPursue(r2,t2)
∧ CareActionType(ca2) ∧ promotedBy(t2,ca2)
∧ ExternalDrugType(d2) ∧ regards(ca2,d2)
∧ incompatibleWith(d2,d-alt) ))
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Fig. 4. UML class diagram for the TMR4I Model - External Interactions.
→ ∃i( AlternativeDrugInteraction(i) ∧ relates(i,r1)
∧ relates(i,ca1) ∧ relates(i,d1) ∧ relates(i,d-alt) )
(12.2) ∀i1, i2, r1( Recommendation(r1)
∧ AlternativeDrugInteraction(i1) ∧ relates(i1,r1)
∧ AlternativeDrugInteraction(i2) ∧ relates(i2,r1) )
→ i1 = i2
In the next section we illustrate the applicability
of the TMR4I model and rules on two case studies
for combining sets of guidelines.
5. Case Studies on Multimorbitidy
This section presents two conceptual experi-
ments on detecting interactions for merged guide-
lines, taken from the literature. They are meant
to provide an implementation independent demon-
stration of the TMR4I model applied to multimor-
bidity; it also illustrates the improvements it offers
compared to the approaches introduced in Sect.
2. The implementation of TMR4I using Semantic
Web languages, discussed in Sect. 6, serves as an
evaluation of the conceptual model, and corrobo-
rates the pen and paper exercise of this section.
The two case studies are:
DU+TIA The first experiment, taken from Wilk
et al. [26], originally presented in [30], com-
bines two guidelines, namely Duodenal Ulcer
(DU) and Transient Ischemic Attack (TIA),
adapted from original guidelines published by
the National Institute for Health and Clinical
Excellence, UK (NICE)3.
OA+HT+DB The second experiment combines 3
guidelines for Osteoarthritis4 (OA), Hyper-
tension5 (HT) and Diabetes6 (DB) taken from
[11].
We make some adaptations to the original case
studies by:
i representing only the recommendations that
are relevant for studying the interactions and
illustrating the approach;
ii simplifying the features that are not yet ad-
dressed by the TMR/TMR4I models (e.g.
time, quantities); and
iii adding some extra recommendations that
serve to better illustrate our approach.
In particular, when the original guidelines taken
from the related work do not provide all informa-
tion that we need in the TMR model, we make
some assumptions based on related paper-based
guidelines or common sense.
We divide the experiment in 3 steps: (1) Acquir-
ing guideline data; (2) Combining guidelines and
detecting interactions and (3) Addressing unde-
sired interactions and verifying the outcome. For
3http://www.nice.org.uk/
4http://www.nhstaysideadtc.scot.nhs.uk/TAPG\%20html/
Section\%2010/osteoarthritis.htm
5http://pathways.nice.org.uk/pathways/hypertension
6http://pathways.nice.org.uk/pathways/diabetes
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each step the results are presented in figures as
instance-schemas of the TMR4I model. They re-
gard the results we would expect to obtain from
an information system that implements the model
and rules described in the previous sections. We
also present and compare with the original ap-
proaches applied to each case study.
5.1. Case Study 1: DU + TIA
This section repeats a conceptual experiment
presented in [30], considering adaptations to the
TMR4I model, with the aim of providing an imple-
mentation for it. This experiment is originally pro-
posed by Wilk et al. [26] on modeling and merging
the guidelines for DU and TIA.
STEP 1: Acquiring guideline data
The original DU guideline, taken from [26], is pre-
sented in Fig. 5. This actionable graph is manu-
ally created from the original paper-based guide-
lines (as well as the one further presented). The
highlighted recommendations are the relevant ones
represented according to the TMR model, illus-
trated as an instance-schema in Fig. 6. The action
Stop Aspirin if used in the original guideline is rep-
resented in the TMR DU guideline as a recommen-
dation named Avoid Bleeding, which recommends
to avoid the transition promoted by the care ac-
tion Administer Aspirin. The undesired transition
can lead from the situation where gastrointestinal
bleeding risk is Low to High. Other two actions
Start Eradication Therapy and Start PPI from the
original guideline are represented as the recom-
mendations named Heal DU, describing that both
the care action Eradication Therapy can lead from
the situation where DU is unhealed to healed when
H.Pylori is positive, and when H.Pylori is nega-
tive instead the care action Administer PPI can
promote a similar transition.
The original TIA guideline, taken from [26], is
presented in Fig. 7. The highlighted recommen-
dations are the relevant ones represented accord-
ing to the TMR model, illustrated as an instance-
schema in Fig. 8. The actions Start Aspirin and
Start Dipyridamole from the original guideline are
represented as the recommendations named Re-
duce Medium Risk VE (Vascular Events) and Re-
duce High Risk VE. They recommend respectively
the transition promoted by the care actions Ad-
minister Aspirin, which leads from Medium Risk
of VE to Low Risk of VE, and the transition
promoted by the care action Administer Dipyri-
damole, which leads from High Risk of VE to Low
Risk of VE.
STEP 2: Combining guidelines and detecting in-
teractions
For combining the two guidelines, Wilk et al. [26]
uses CLP to identify and resolve conflicts in two
guidelines by consulting a MBK, locally defined,
describing possibly conflicting actions/recommen-
dations and their alternative solutions according
to experts. For example, the MBK states that the
recommendations Stop Aspirin if used and Start
Aspirin cannot coexist. Since this combination in-
deed occurs in the combined version of guidelines,
a conflict is identified.
Counterwise, the TMR4I model allows to sis-
tematically identify interactions among recom-
mendations by using the defined rules, as de-
picted in Fig. 9. A contradiction interaction be-
tween the recommendations Avoid Bleeding and
Reduce Medium Risk VE is identified since they
recommend to pursue and to avoid transitions that
are promoted by the same Care Action Type. An
alternative interaction is identified between the
two recommendations named Heal Duodenal Ul-
cer, since they recommend similar transitions7.
The care actions and transitions are connected to
an external drug dataset.
STEP 3: Addressing undesired interactions and
verifying the outcome
In order to address the identified conflict in Wilk
et al. [26] approach, the MBK provides two solu-
tions: (i) substitute Aspirin by Clopidogrel; and
(ii) combine Aspirin treatment with PPI. The au-
thors choose the second option and introduced it
in the merged guideline as Start PPI when the
risk of stroke is elevated, and also excluded the
recommendation Stop Aspirin if used in order to
avoid the conflict. Although their outcome would
be verifiable by reapplying their approach, the
authors did not perform such verification. How-
ever, in order to be effective, the possible conflicts
would have to be included in the MBK. Finally,
since their final goal was not to produce a generic
combined version of guidelines, but to prescribe a
7The recommendation Reduce High Risk VE is omitted
for sake of simplicity, since it does not have related inter-
actions.
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Fig. 5. DU guideline taken from [26].
DU Guideline Transitions by Care Actions
Gastrointestinal Bleeding
high riskAdministerAspirinlow riskAvoid Bleeding do not
Duodenal Ulcer
healedEradication Therapyunhealed
Heal Duodenal 
Ulcer do
H.Pylori
positive
Duodenal Ulcer
healedAdminister PPIunhealed
Heal Duodenal 
Ulcer do
H.Pylori
negative
Fig. 6. DU guideline according to TMR Model.
Fig. 7. TIA guideline taken from [26].
TIA Guideline Transitions by Care Actions
Vascular Events
low riskAdminister Aspirin
medium
risk
Reduce medium 
risk VE do
Vascular Events
low riskAdminister Dipyridamole
high
risk
Reduce high risk 
VE do
Fig. 8. TIA guideline according to TMR Model.
treatment for a specific patient, they proposed a
solution that is applicable to a specific patient.
In our approach both the proposed solutions
are introduced as recommendations, without ex-
cluding the recommendation Avoid Bleeding. They
are named Protect Duodenum and Reduce Medium
Risk VE as depicted in Fig. 10 (the original rec-
ommendations are presented in gray shade). Natu-
rally, alternative interactions are derived between
the original recommendations and the new ones.
On the one hand, Protect Duodenum recommends
a transition that reverse the undesired transition
recommended to be avoided by Avoid Bleeding.
On the other hand, the new recommendation Re-
duce Medium Risk VE recommend a similar tran-
sition. Moreover, a repetition interaction can also
be identified between the recommendations Pro-
tect Duodenum and Heal DU, since they both rec-
ommends the same Care Action Administer PPI.
Therefore, the combined DU-TIA guideline that
we produced does not eliminate the original con-
flict but allows it to be avoided by introducing one
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DU + TIA Guideline 
contradiction
alternative
Vascular Events
low riskAdminister Aspirin
medium
risk
Reduce medium 
risk VE do
Duodenal Ulcer
healedEradication Therapyunhealed
Heal Duodenal 
Ulcer do
H.Pylori
positive
Gastrointestinal Bleeding
high riskAdministerAspirinlow riskAvoid Bleeding do not
Transitions by Care Actions
Duodenal Ulcer
healedAdminister PPIunhealed
Heal Duodenal 
Ulcer do
H.Pylori
negative
Fig. 9. Combined DU+TIA guideline according to TMR
model with detected interactions.
Gastrointestinal Bleeding
high riskAdministerAspirinlow riskAvoid Bleeding
Heal Duodenal 
Ulcer
Heal Duodenal 
Ulcer
Vascular Events
low riskAdminister Aspirin
medium
risk
Reduce medium 
risk VE
contradiction
alternative
Protect 
Duodenum do
Vascular Events
low riskAdminister Clopidogrel
medium
risk
Reduce medium 
risk VE do
Duodenal Ulcer
healedAdminister PPIunhealeddo
H.Pylori
negative
Duodenal Ulcer
healedEradication Therapyunhealeddo
H.Pylori
positive
do
do not
Transitions by Care Actions
Gastrointestinal Bleeding
high risk low riskAdminister PPI
alternative
repetition
alternative
DU + TIA Guideline 
Fig. 10. Combined DU+TIA guideline according to
TMR model, including the new recommendations and
detected interactions.
or more alternative recommendations. Actually
the recommendation Avoid Bleeding is not elimi-
nated since it is a restriction that holds for DU pa-
tients regardless what else disease they could have.
Indeed, the resultant guideline is both (i) appli-
cable to many patients and (ii) liable to further
combination with other guidelines or treatments
that the patient already follows. Finally, the in-
ternal interactions are identified by relying on the
detailed semantics for the recommendations and
guideline-independent rules without (necessarily)
consulting a MBK.
5.2. Case Study 2: OA + HT + DB
This section presents a new experiment taken
from Jafarpour’s thesis [11], on combining three
guidelines, namely OA, HT and DB. This is meant
for illustrating the ability to (i) identify internal
interactions between more than two recommenda-
tions, combining more than two guidelines, and (ii)
identify external interactions. We first introduce
how the experiment was originally addressed and
then we discuss and compare with our approach.
In Jafarpour’s approach the guideline data is
acquired by manually instantiating an ontology.
Then constraints are manually created to resolve
conflicts between tasks (recommendations) from
two guidelines, as illustrated in Fig. 11. The three
tasks regarding the administration of Ibuprofen or
Naproxen are considered to be in conflict with the
hypertension pathway, since these drugs may in-
crease the blood pressure, according to experts.
The constraints named conflict 1, 2 and 3 are
introduced suggesting the replacement of these
drugs by Tramadol or similar. The role of these
constraints is to interfere in the execution of the
guidelines, i.e. when a task that is to be executed
has one of these constraints associated, then in-
stead of executing the task, the constraint instruc-
tion will be followed. In this example, the instruc-
tions are for substituting the task.
The goal in Jafarpour’s approach (further dis-
cussed in Sect. 8) is to produce a reusable pair-
wise combination of guidelines, such that several
pairwised combined guidelines can be executed to-
gether to handle multi-morbidity. Besides the com-
bination of OA+HT, the approach is applied to
combine OA+DB and HT+DB such that the three
of them can be executed together. However, the
solution proposed in this example introduces a
repetition interaction, according to the definition
presented in 4.1, since Tramadol is recommended
four times: in order to address the aforementioned
conflicts and also to address another conflict be-
tween OA and DB recommendations, where Tra-
madol is recommended to replace Aspirin as anti-
thrombotic. Since recommending the same drug
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Fig. 11. The instantiation of the CPG-KPO and the parts
of the OA and HT guidelines that participate in the merge,
taken from [11].
more than once may lead to overdose, it requires
attention from the experts. Jafarpour’s approach
does not detect the interaction we just mentioned.
STEP 1: Acquiring guideline data
Hereby we present our solution for merging guide-
line for OA+HT+DB (for sake of simplicity figures
are omitted for this step). First, we represent for
each guidelines the recommendations that are in-
volved in the conflicts detected by Jafarpour. Then
the effects that must be avoided for each disease,
which are the reason for the conflicts, are explic-
itly represented as recommendations within each
guideline (if this information is not yet available).
For instance for detecting the aforementioned con-
flict the recommendation Avoid High Blood Pres-
sure promoted by Administering Aspirin is explic-
itly introduced in the HT guideline. Avoid Bleed-
ing and Avoid High Blood Sugar Level are intro-
duced respectively in OA and DB guidelines. Al-
though this resembles the manual identification of
the interactions, it is actually not the case. Once
this information is available as part of the guide-
line, it can be reused to derive many interactions.
The care actions and transitions are connected to
an external drug dataset.
STEP 2: Combining guidelines and detecting in-
teractions
The recommendations from the original guidelines
are reused in order to create a merged guideline,
as depicted in Fig. 12 according to the TMR4I
model, and interactions manually identified by Ja-
farpour can be derived: (i) Administer ibuprofen
to relief pain from OA contradicts Do not admin-
ster ibuprofen to avoid increase the blood pres-
sure from HT; (ii) Administer thiazide to lower the
blood pressure from HT contradicts Do not admin-
ster thiazide to avoid increase the level of blood
sugar from DB; and (iii) Administer aspirin to
lower the risk of thrombus from DB contradicts Do
not adminster aspirin to avoid increase the risk
of gastro-intestinal bleeding from OA. Moreover,
and alternative interaction is identified among the
recommendations Avoid High Blood Pressure and
Reduce Blood Pressure since the latter reverse the
undesired effect according to the former.
STEP 3: Addressing undesired interactions and
verifying the outcome
In order to address the contradiction interac-
tions, two solutions proposed by Jafarpour are
introduced as recommendations (one of the so-
lutions, regarding reducing the quantity, is not
addressed, since it is out of scope of this work)
and more interactions are derived, as depicted in
Fig. 13 (the original recommendations are pre-
sented in gray shade). (i) an alternative interac-
tion is derived between recommendations for Re-
duce Pain, (ii) another alternative interaction is
derived between the three Avoid Thrombi recom-
mendations and (iii) a repetition interaction is
derived among the introduced recommendations
for Administering Tramadol. Moreover, an extra
recommendation Avoid Thrombi promoted by Ad-
minister Clopidogrel is added in order to better
illustrate the cumulative alternative interaction.
Since the resultant guideline can be further veri-
fied by applying the same method,
In addition, external interactions can also be
identified besides the internal ones, once the orig-
inal care actions and transitions are connected
to an external drug dataset. Particularly in this
case study, the recommendations Avoid Thrombi
and Reduce Pain have an Incompatible Drug In-
teraction since the drug types Aspirin and Ibupro-
fen, associated to the respective care actions, in-
teracts to each other. Moreover, Alternative Drug
Interactions can be identified as possible solu-
tion for the recommendations involved in an un-
desired interaction. For example, the recommen-
dation Avoid Thrombi, being involved in contra-
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DB
HT
OA
OA+HT+DB Guideline 
alternative
contradiction
contradiction
contradiction
Gastrointestinal Bleeding
high 
risk
Administer
Aspirin
low
risk
Avoid Bleeding do not
Blood Pressure
highAdminister Ibuprofennormal
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Blood Pressure do not
Blood Sugar Level
highAdminister Thiazidenormal
Avoid High Blood 
Sugar Level do not
Pain
no painAdminister Ibuprofenpain
Reduce Pain do
Blood Pressure
lowAdminister Thiazidehigh
Reduce Blood 
Pressure do
Transitions by Care Actions
Avoid Thrombi do
Risk of Thrombus
low riskAdminister Aspirin
medium 
risk
Fig. 12. Instance-schema illustrating the OA+HT+DB
guideline and three contradictory interactions derived.
contradiction
repetition
 DB
HT
OA
Gastrointestinal Bleeding
high 
risk
Administer
Aspirin
low
risk
Avoid Bleeding do not
Blood Pressure
highAdminister Ibuprofennormal
Avoid High 
Blood Pressure do not
Blood Sugar Level
highAdminister Thiazidenormal
Avoid High Blood 
Sugar Level do not
Pain
no painAdminister Ibuprofenpain
Reduce Pain do
Blood Pressure
lowAdminister Thiazidehigh
Reduce Blood 
Pressure do
Risk of Thrombus
low riskAdminister Aspirin
medium 
risk
Avoid Thrombi do
Transitions by Care Actions
contradiction
alternative
contradiction
Gastrointestinal Bleeding
no painAdminister Tramadolpain
Reduce Pain do
Risk of Thrombus
low riskAdminister Tramadol
some
risk
Avoid Thrombi do
Risk of Thrombus
low riskAdminister Clopidogrel
some
risk
Avoid Thrombi do
OA+HT+DB Guideline 
alternative
alternative
Fig. 13. Instance-schema illustrating new recommenda-
tions and derived interactions for OA+HT+DB guide-
line.
diction and incompatible drug interactions, has al-
ternative drugs (e.g. Epoprostenol) that can be
retrieved according to the drug category (anti-
platelet) related to the pursued transition (reduce
risk of thrombus).
By performing this conceptual experiment we
demonstrate that the TMR4I approach allows a
more systematic detection of internal interactions
both after combining guidelines and after intro-
ducing new recommendations in order to address
the interactions. This approach favor the autom-
atization of this task, in contrast with Jafarpour
approach that requires ad-hoc interaction rules.
6. Evaluation
This section provides an evaluation for the
TMR/TMR4I models and rules by implement-
ing them using Semantic Web representation lan-
guages. The goal is to use the Semantic Web to
provide a technical solution that applies our con-
ceptual approach into a concrete Web application,
available online8. We instantiate the case studies
discussed in Sect. 5 as individuals in our knowledge
base. We then use Semantic Web inferencing to
automatically derive the interactions we predicted
the TMR4I model would infer.
The implementation itself is presented in Sect.
6.1, and Sect. 6.2 focuses on the instantiation of
the case studies.
6.1. Implementation of the TMR Models
The TMR and TMR4I models have a very
straightforward implementation in OWL 2. To
8See http://guidelines.hoekstra.ops.few.vu.nl/, and
GitHub https://github.com/Data2Semantics/guidelines/
tree/v1.0.
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guarantee the content independence of the model
(cf. [26]), the schema information (OWL2, rules)
and queries are generic and specified indepen-
dently from the representation of individual guide-
lines. The latter are represented as individuals –
instances – in the triple store.
All unary predicates in the rules 1.1 through
12.2 in Sect. 3 and 4 are classes, and all bi-
nary predicates are either object properties, or an
equivalent from the OWL and RDFS vocabulary.
The class and property subsumption hierarchy, do-
main and range restrictions, as well as cardinality
constrains follow the structure of the UML class
diagrams in figures 1, 3, and 4.
Not all rules can be translated to OWL restric-
tions because of the tree-model property that un-
derlies the SROIQ(D) description logic of OWL 2
[8]: an OWL class restriction can only fan out to
form a tree shape of which the branches do not
connect. This essentially means that two variables
introduced in the antecedent of a rule, that are
transitively connected through predicates in the
antecedent, cannot be connected by a predicate in
the consequent of the rule. For example, one can-
not represent the fact that the four legs of a ta-
ble must touch the same floor (unless only a single
floor exists in the universe).
There are partial workarounds for this limita-
tion by using property chains [6,5], but for all
practical purposes we implemented the restric-
tions that couldn’t be expressed in OWL2 using a
combination of SPARQL queries and the Stardog
Rules Syntax,9 an alternative to the more stan-
dard SWRL.10 Stardog Rules Syntax is a SWRL
implementation that uses SPARQL syntax [19,20].
It has the advantage of being more readable, but
also more expressive in that it allows the use of
SPARQL niceties such as filters, property paths
and blank nodes. Stardog is a triple store that sup-
ports OWL2, SWRL and integrity constraints rea-
soning at query time.11
Another drawback of OWL2 and SWRL-style
inferencing is that these allow only for inferring
the existence of unnamed entities implicitly. For
instance, if we know that two transitions are re-
lated, we cannot assert an interaction-individual
that relates the respective recommendations. To
9See http://docs.stardog.com/owl2/.
10See http://www.w3.org/Submission/SWRL/
11See http://www.stardog.com.
overcome this limitation, we programmatically in-
troduce these individuals in our knowledge base
using SPARQL select queries.
The following sections illustrate the implemen-
tation of our model. We first give an example in-
stantiation of a recommendation, followed by a
discussion of the rules for internal interactions,
and those for external interactions (ones that in-
volve external knowledge, or MBK). For reference,
listing 1 presents the prefixes used in the code ex-
amples.
6.1.1. Example Recommendation
The listing 2 provides a short example of an in-
stantiation of the TMR4I model for the recommen-
dation :RecDB-AntiThrombotic to ‘avoid thrombi’
that is part of the Diabetes Mellitus guideline
(:CIG-DB). It promotes a transition :T4 that aims
to lower the risk of a thrombus from medium to
low by means of the :ActAdministerAspirin care
action type. This care action is linked to the ex-
ternal identifier DB00945 for the drug (Aspirin) in
DrugBank, through the tmr4i:involves relation.
6.1.2. Implementation of Internal Interactions
In our knowledge base, the example recommen-
dation in listing 2 does not exist in isolation:
there are several more guidelines, recommenda-
tions, transitions and care action types (as dis-
cussed previously). In TMR4I, the internal inter-
actions between recommendations are derived fol-
lowing the FOL rules in Sect. 4.1. The implemen-
tation of these rules is by means of a SPARQL se-
lect query that retrieves every two recommenda-
tions that matches the pattern in those rules:
– there exists a tmr4i:simlarToTransition be-
tween the transitions recommended by two
recommendations (see listing 3, the other
rules are similar); or
– there is a tmr4i:inverseToTransition be-
tween them; or
– the transitions are tmr4i:promotedBy the
same care action.
Then, a SPARQL insert is executed for each pair
of recommendations, creating a new individual of
type tmr4i:InternalInteraction and relating it to
them12.
12This is necessary to work around the limitations of
SWRL and OWL with respect to the assertion of new in-
dividuals.
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1 PREFIX tmr4i: <http://guidelines.data2semantics.org/vocab/>
2 PREFIX owl: <http://www.w3.org/2002/07/owl#>
3 PREFIX drugbank: <http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugbank/>
4 PREFIX drugCat: <http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugcategory/> .
5 PREFIX drug: <http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/>
Listing 1: Prefixes used in SPARQL queries (and Turtle examples).
1 # The Guideline for Diabetes
2 :CIG-DB
3 a tmr4i:Guideline ,
4 owl:NamedIndividual ;
5 rdfs:label "CIG for Diabetes Mellitus"@en .
6
7 # A Recommendation
8 :RecDB-AntiThrombotic
9 a tmr4i:Recommendation ,
10 owl:NamedIndividual ;
11 rdfs:label "Avoid thrombi"@en ;
12 tmr4i:partOf :CIG-DB ;
13 tmr4i:recommendsToPursue :T4 .
14
15 # A transition
16 :T4 a tmr4i:Transition ,
17 owl:NamedIndividual ;
18 tmr4i:promotedBy :ActAdministerAspirin ;
19 tmr4i:hasExpectedPostSituation
20 :SitLowRiskThrombus ;
21 tmr4i:hasTransformableSituation
22 :SitMediumRiskThrombus .
23
24 # The care action type that promotes the transition
25 :ActAdministerAspirin
26 a tmr4i:CareActionType ,
27 owl:NamedIndividual ;
28 rdfs:label "Administer Aspirin"@en .
29 # Link to a DrugBank identifier
30 tmr4i:involves drug:DB00945 .
Listing 2: Excerpt of the TMR4I-based represen-
tation of a recommendation to ‘Avoid thrombi’.
The classification of the interaction type is again
done via SPARQL Rules. The code on Listing 4
presents the implementation of the FOL rule 8.1
defined in Sect. 4.1: if a tmr4i:InternalRecommen-
dationInteraction relates two tmr4i:Recommen-
dation instances that both tmr4i:recommendsTo-
Pursue two transitions, which have a tmr4i:simi-
larToTransition relation, then the interaction is
of the type tmr4i:AlternativeDueToSimilarTran-
sition. The other FOL rules have similar imple-
mentations.
As one can see, these rules are generic; they only
use vocabulary of the TMR and TMR4I models
1 [] a rule:SPARQLRule;
2 rule:content """
3 IF {
4 ?ca1 a tmr4i:CareActionType,
5 owl:NamedIndividual .
6 ?ca2 a tmr4i:CareActionType,
7 owl:NamedIndividual .
8 ?sa a tmr4i:SituationType,
9 owl:NamedIndividual .
10 ?sb a tmr4i:SituationType,
11 owl:NamedIndividual .
12 ?t1 a tmr4i:Transition,
13 owl:NamedIndividual .
14 ?t2 a tmr4i:Transition,
15 owl:NamedIndividual .
16 ?t1 tmr4i:hasExpectedPostSituation ?sb .
17 ?t2 tmr4i:hasExpectedPostSituation ?sb .
18 ?t1 tmr4i:hasTransformableSituation ?sa .
19 ?t2 tmr4i:hasTransformableSituation ?sa .
20 ?t1 tmr4i:promotedBy ?ca1 .
21 ?t2 tmr4i:promotedBy ?ca2 .
22 ?ca1 a owl:NamedIndividual .
23 ?ca2 a owl:NamedIndividual .
24 FILTER (?ca1 != ?ca2 && ?t1 != ?t2)
25 } THEN {
26 ?t1 tmr4i:similarToTransition ?t2 .
27 }""" .
Listing 3: Stardog rule for inferring
tmr4i:similarToTransition relations.
themselves, and do not contain any specifics of the
guidelines discussed in the previous sections.
6.1.3. Implementation of the External
Interactions
In order to connect to external knowledge bases
it is not needed to explicitly instantiate the class
External Information (from Fig. 4) but we can use
external identifiers (URIs) directly in our knowl-
edge base. For instance, the Turtle code in Listing
2 connects a care action to the representation of
Aspirin in DrugBank. Of course, these links have
to be added to the care actions by hand, but only
once; since care actions are reused across transi-
tions, and transitions are reused across recommen-
dations, which can be reused across guidelines (as
we will see below).
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1 [] a rule:SPARQLRule;
2 rule:content """
3 IF {
4 ?i a tmr4i:InternalRecommendationInteraction;
5 tmr4i:relates ?r1, ?r2 .
6 ?r1 a tmr4i:Recommendation,
7 owl:NamedIndividual .
8 ?r2 a tmr4i:Recommendation,
9 owl:NamedIndividual .
10 ?r1 tmr4i:recommendsToPursue ?t1 .
11 ?r2 tmr4i:recommendsToPursue ?t2 .
12 ?t1 a owl:NamedIndividual .
13 ?t2 a owl:NamedIndividual .
14 ?t1 tmr4i:similarToTransition ?t2 .
15 FILTER(?r1 != ?r2)
16 } THEN {
17 ?i a tmr4i:AlternativeDueToSimilarTransition .
18 }""".
Listing 4: SPARQL rule for classifying Alternative
Interactions due similar transitions (FOL 8.1).
In addition to the direct link between a care ac-
tion and a drug, we also use the drug category in-
formation present in DrugBank: the category cap-
tures the type of drug, i.e. what its desired effect
is (drugs can belong to multiple categories at the
same time). TMR4I links drug categories to in-
stances of the tmr4i:Transition class using the
tmr4i:regards property (see listing 5).
For scalability reasons, our knowledge base in-
cludes an excerpt of the Linked Data version
of DrugBank as published by the University of
Mannheim13 that contains all drug names, drug
categories and the drug-drug interactions. The ex-
cerpt is made available through our GitHub repos-
itory.14
In order to detect external interactions, we pro-
ceeded in a way similar to the internal ones.
However, we used two specific queries for imple-
menting the FOL rules 11 and 12.1 (defined in
Sect. 4.2) for incompatible drug interaction and
alternative drug interaction. The first uses the
drug-drug interaction information from DrugBank
to detect unique pairs of recommendations that
interact because the care actions that promote
the recommended transitions involve drugs that
form an interaction pair on DrugBank (listing
6). As with the internal interactions, the system
13See http://wifo5-03.informatik.uni-mannheim.de/
drugbank/
14See https://github.com/Data2Semantics/guidelines/
blob/v1.0/src/data/drugbank_small.nt.
1 :ActAdministerAspirin
2 a tmr4i:CareActionType ;
3 tmr4i:involves drug:DB00945 .
4 :ActAdministerClopidogrel
5 a tmr4i:CareActionType ;
6 tmr4i:involves drug:DB00758 .
7
8 :T2 a tmr4i:Transition ;
9 tmr4i:regards drugCat:anti-bacterialAgents .
10 :T3 a tmr4i:Transition ;
11 tmr4i:regards drugCat:proton-pumpInhibitors .
Listing 5: Example connections to DrugBank.
1 SELECT distinct ?r1 ?r2 ?d1 ?d2
2 WHERE {
3 ?r1 tmr4i:partOf ?g;
4 tmr4i:recommendsToPursue ?t1.
5 ?r2 tmr4i:partOf ?g;
6 tmr4i:recommendsToPursue ?t2.
7 ?t1 tmr4i:promotedBy ?ca1 .
8 ?t2 tmr4i:promotedBy ?ca2 .
9 ?ca1 tmr4i:involves ?d1 .
10 ?ca2 tmr4i:involves ?d2 .
11 ?d1 drugbank:interactsWith ?d2 .
12
13 FILTER(?r1 != ?r2 && ?d1 != ?d2 && ?ca1 != ?ca2 )
14 # Avoid duplicates
15 FILTER NOT EXISTS {
16 ?iir a tmr4i:IncompatibleDrugExternalInteraction .
17 ?iir tmr4i:relates ?r1 .
18 ?iir tmr4i:relates ?r2 .
19 }
20 }
Listing 6: SPARQL query for selecting the pairs
of recommendation that fit the pattern to be re-
lated by an external incompatible drug interaction
(FOL 11).
then asserts corresponding new instances of the
tmr4i:IncompatibleDrugExternalInteraction class
for each pair.
The second tries to identify non-interacting
alternative drugs based on the drug category
specified for transitions that cause a contradic-
tion or incompatibility between recommendations
(listing 7). The result of this SPARQL query
is a reified relation between a recommendation,
a care action, a drug and the alternative drug
found. As with the internal interactions, the sys-
tem then asserts corresponding new instances of
the tmr4i:AlternativeDrugExternalInteraction
class for each unique reified relation.
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1 SELECT DISTINCT ?rec ?ca ?d ?dALT
2 WHERE {
3 {
4 {?i a tmr4i:ContradictionDueToSameAction .}
5 UNION
6 {?i a tmr4i:ContradictionDueToInverseTransition .}
7 UNION
8 {?i a tmr4i:ContradictionDueToSimiliarTransition .}
9 UNION
10 {?i a tmr4i:IncompatibleDrugExternalInteraction .}
11 }
12 ?i tmr4i:relates ?rec .
13 ?rec tmr4i:recommendsToPursue ?t;
14 tmr4i:partOf ?g .
15 ?t tmr4i:promotedBy ?ca .
16 ?ca tmr4i:involves ?d .
17 ?t tmr4i:regards ?dc .
18 ?dALT drugbank:drugCategory ?dc .
19
20 FILTER (?d != ?dALT) .
21 # Filter incompatible drugs
22 FILTER NOT EXISTS {
23 ?dALT drugbank:interactsWith ?d2 .
24 ?ca2 tmr4i:involves ?d2 .
25 ?t2 tmr4i:promotedBy ?ca2 .
26 ?rec2 tmr4i:recommendsToPursue ?t2 .
27 ?rec2 tmr4i:partOf ?g .
28 FILTER(?dALT != ?d2)
29 }
30 # Avoid duplicates
31 FILTER NOT EXISTS {
32 ?iir a tmr4i:AlternativeDrugExternalInteraction .
33 ?iir tmr4i:relates ?rec .
34 ?iir tmr4i:relates ?ca .
35 ?iir tmr4i:drug ?d .
36 ?iir tmr4i:alternative_drug ?dALT .
37 }
38 }
Listing 7: SPARQL query for selecting the recom-
mendations that fit the pattern to be related by an
external alternative drug interaction (FOL 12.1).
On doing so we are able to infer the existence
of external interactions and classify them accord-
ing to the FOL definitions we provided, preserving
their structure. This is a limited but important im-
provement on allowing the identification of drug-
drug incompatibilities as well as alternative drugs
without human intervention (except for linking the
care actions and transitions to DrugBank).
6.2. Populating the Knowledge Base
This section briefly discusses how the knowledge
base is populated. Because all necessary knowl-
edge for inferring the interactions are part of the
schema of the knowledge base, the representation
of a guideline is only at the instance level. In list-
ing 2 we already provided an example of what an
instantiation of the model for a single recommen-
dation looks like. At the moment this is still a
manual process: all guidelines, recommendations,
transitions and care actions are modeled using an
editor of choice.
In order to repeat the experiment described in
the section on the two case studies (Sect. 5) we
proceed as follows:
STEP 1 - All the data for the original guidelines
is manually entered. The care actions and transi-
tions are linked to the corresponding drug types
and categories from DrugBank. We aim to facili-
tate this step with a simple web-based user inter-
face.
STEP 2 - To simulate the merging of the guide-
lines, a new merged guideline is created that du-
plicates recommendations from the original guide-
lines, and directly reuses the information about
transitions and care actions contained in them. As
a result, transitions and care actions are not du-
plicated across guidelines, but shared. Once the
SPARQL-based inferences are run, the internal
and external interactions are created and classified
within the merged guidelines.
STEP 3 - In order to address contradictory in-
teractions, alternative recommendations can be in-
troduced to the merged guidelines. Again, once the
rules are executed, eventual new interactions are
derived.
Finally, in order to verify the cumulative inter-
actions, a SPARQL query retrieves recommenda-
tions whose interactions relate more than two rec-
ommendations. In other words, it retrieves the rec-
ommendations whose interactions are related by
owl:sameAs, the type of interaction, including pur-
sued or avoided transition, pre and post situations
and care action.
Given the definitions of which and how inter-
actions can be identified according to the TMR4I
model, we present in the next section an approach
of how to apply this model in a multimorbidity
case study.
7. Results
This section brings the results we obtained by
instantiating the two case studies using the im-
V. Zamborlini et al. / Inferring Recommendation Interactions in Clinical Guidelines 21
plementation described in the preceding section.
The results are presented in tables that present
the data retrieved after each step proposed in the
previous sections. We also developed a Web-based
application that allows to explore both the orig-
inal guidelines and the combined ones, and their
associated recommendations, transitions and care
actions.15
Web-based Guideline Explorer The Web-based
guideline explorer is a jQuery + Python Flask ap-
plication that uses SPARQL queries to interact
with the Stardog triple store in which the TMR4I
model and guideline representations reside.16
Figure 14 shows a screen-shot of the application
presents on the left hand side the combined guide-
line for OA+HT+DB and its interactions. When
the recommendation Avoid Thrombi by Adminis-
tering Aspirin is selected, its details are presented
on the right hand side, including the internal and
external interactions inferred and explained in a
human readable format. By positioning the cursor
over an orange interaction, the other recommen-
dation involved in that interaction is highlighted
in orange on the left.
In summary, this recommendation says (at the
bottom) that the transition for Reducing the Risk
of Thrombus can be achieved by executing the
care action Administer Aspirin and that there are
two other, similar transitions recommended in this
guideline (T13 and T7, recommended twice). This
recommendation has (i) one contradiction interac-
tion since a care action it recommends is also rec-
ommended to be avoided; (ii) one cumulative alter-
native interaction that involves two other recom-
mendations with similar transitions; (iii) one ex-
ternal drug interaction because Aspirin interacts
with Ibuprofen according to DrugBank, and (iv)
one alternative care action, namely Epoprostenol,
that may alleviate this interaction according to
DrugBank.
Step 1 - Data Acquisition Table 3 presents the
original recommendations introduced for DU and
TIA guidelines (the other guidelines are omitted
for sake of simplicity).
15The web application is running at http://guidelines.
hoekstra.ops.few.vu.nl
16See http://jquery.com, http://flask.pocoo.org, http:
//www.stardog.com.
Step 2 and 3 - Inferences Tables 4 and 5 present
the results obtained after steps 2 and 3, for re-
spectively the first (DU+TIA) and second use case
(OA+HT+DB). The new recommendations and
interactions added in step 3 are highlighted in
bold. Recommendations presenting more than one
interaction appear in the table just once but fol-
lowed by “empty” line(s) containing just the de-
rived interaction type.
Cumulative Interactions Table 6 presents the
recommendations related by cumulative interac-
tions.
8. Discussion and Future Work
The outcomes from the two experiments shown
that different types of interactions can be (semi)
automatically detected in multimorbidity cases by
applying TMR4I model, enriched with Semantic
Web features. In opposed to the original experi-
ments reported in related work, in both case stud-
ies the internal interactions are detect without
need for specific MBK or rules, but relying on the
detailed semantics provided for the recommenda-
tions. Interactions with cumulative behavior (e.g.
alternative) are detected among more than two
recommendations. Another important difference
is that the final outcome, including the merged
guidelines and the recommendations introduced to
address the conflicts, can be verified again using
the very same approach. Finally, DrugBank is used
for automatically detecting interactions that could
not be derived from the data comprised in the
guidelines.
In what follows we provide a comparison be-
tween our approach and the others that we anal-
ysed in Sect. 2, summarized in Table 7:
Core concepts. Although the analysed approaches
also use rules/constraints to identify the interac-
tions among actions and to propose solutions, they
do not support a guideline-independent detec-
tion of interactions either because the formalism
adopted (Wilk [26], Lopez-Vallverdu [14]) is not
expressive enough or the model (Jafarpour [11])
does not favour the reuse of rules. For instance,
to detect the inconsistency between the recom-
mendations Administer Aspirin & Avoid Adminis-
tering Aspirin a context-specific rule is proposed.
However, for other substances (e.g. if there is in-
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Fig. 14. Screenshot of the live Web application, running at http://guidelines.hoekstra.ops.few.vu.nl.
Table 3
Recommendations for original DU and TIA guidelines.
guide-
line
Recommendation Mode pre Situation post Situation Care Action
DU Avoid bleeding Avoid Risk of Gastrointestinal
Bleeding is Low
Risk of Gastrointestinal
Bleeding is High
Administer
Aspirin
DU Heal duodenal ulcer Pursue Ulcer is unhealed Ulcer is healed Administer PPI
DU Heal duodenal ulcer Pursue Ulcer is unhealed Ulcer is healed Eradication
Therapy
TIA Reduce high blood
pressure
Pursue Risk of Thrombus is High Risk of Thrombus is Low Administer
Dipyridamole
TIA Reduce medium
risk VE
Pursue Risk of Thrombus is Medium Risk of Thrombus is Low Administer
Aspirin
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Table 4
DU-TIA - Recommendations and respective new interaction types detected after adding new recommendations (highlighted).
Recommenda-
tion
Mode pre Situation post Situation Care Action Interaction Type
Avoid bleeding Avoid Risk of Gastrointestinal
Bleeding is Low
Risk of Gastrointestinal
Bleeding is High
Administer
Aspirin
Contradiction Due To
Same Action
Alternative Due To
Inverse Transition
Heal duodenal
ulcer
Pursue Ulcer is unhealed Ulcer is healed Administer
PPI
Alternative Due To
Similar Transition
Repetition Due To Same
Action
Heal duodenal
ulcer
Pursue Ulcer is unhealed Ulcer is healed Eradication
Therapy
Alternative Due To
Similar Transition
Protect
duodenum
Pursue Risk of Gastrointestinal
Bleeding is High
Risk of Gastrointestinal
Bleeding is Low
Administer PPI Alternative Due To
Inverse Transition
Repetition Due To Same
Action
Reduce high
risk VE
Pursue Risk of Thrombus is
High
Risk of Thrombus is Low Administer
Dipyridamole
none
Reduce
medium risk
VE
Pursue Risk of Thrombus is
Medium
Risk of Thrombus is Low Administer
Aspirin
Contradiction Due To
Same Action
Alternative Due To
Similar Transition
Reduce medium
risk VE
Pursue Risk of Thrombus is
Medium
Risk of Thrombus is Low Administer
Clopidogrel
Alternative Due To
Similar Transition
consistency with insulin administration instead of
aspirin) a new rule is required. In our approach
we rely on the TMR concepts to define guideline-
independent rules for detecting some interaction
types. For the same example, the inconsistency
between Administer Aspirin and Avoid Adminis-
tering Aspirin is detected by a generic rule that
can be applied to other substances (e.g. Insulin).
Representation of recommendations. In all the
studied approaches, the representation of the rec-
ommendations occur in a textual form, collapsing
both concepts recommendation and action, and
eventually pre and post-conditions. For instance,
Administer Aspirin and Avoid Administering As-
pirin are an example of opposed recommendations
about the same action that are represented as two
different actions instead. The textual description is
used to collapse the positive and negative aspects
of the recommendation and the action itself. Such
characteristic render it difficult the automatic de-
tection of this type of interaction. We instead pro-
pose a more structured representation of the rec-
ommendation and its related concepts, the TMR
model, which favor reasoning about it (although
it also has textual labels for describing each con-
cept). Moreover, the relate work impose the ac-
tions to be in a sequence, when it is actually not
always the case. For instance, Avoid Administering
Aspirin is a recommendation that does not need to
happen before or after another one. Therefore, we
chose a declarative representation of recommenda-
tions in principle, while a sequence of recommen-
dations will be an optional feature investigated as
future work.
Languages. As highlighted in this section, the
description languages used to represent guide-
lines can introduce limitations to the reasoning
process. This is the case for Wilk’s and Lopez-
Vallverdu’s approaches that can only analyse
pairwise recommendations. Jafarpour’s approach
adopted OWL+SWRL languages that are more
flexible to deal with multimorbidities. We concep-
tually describe our approach using FOL and UML
what give us more liberty to select the computer
language later. We adopt OWL+SPARQL for im-
plementation in order to benefit of available Se-
mantic Web features.
Medical background knowledge. Since we based
our implementation on Semantic Web technologies
and there are many semantically described knowl-
edge bases available in the Web, we can evalu-
ate our approach without requiring experts from
biomedical domain to create and validate propri-
etary databases. The same was not observed in the
other approaches, which either define it themselves
or do not use it.
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Table 5
OA+HT+DB - Recommendations and respective new interaction types detected after adding new recommendations
(highlighted).
Recommendation Mode pre Situation post Situation Care Action Interaction Type
Avoid bleeding Avoid Risk of Gastrointestinal
Bleeding is Low
Risk of Gastrointestinal
Bleeding is High
Administer
Aspirin
Contradiction Due To
Same Action
Avoid high blood
pressure
Avoid Blood Pressure is
Normal
Blood Pressure is High Administer
Ibuprofen
Alternative Due To
Inverse Transition
Contradiction Due To
Same Action
Avoid high blood
sugar level
Avoid Level of Blood Sugar is
Normal
Level of Blood Sugar is
High
Administer
Thiazide
Contradiction Due To
Same Action
Avoid thrombi Pursue Risk of Thrombus is
Medium
Risk of Thrombus is Low Administer
Aspirin
Contradiction Due To
Same Action
Incompatible Drug
External Interaction
Alternative Drug External
Interaction
Alternative Due To Similar
Transition
Avoid thrombi Pursue Risk of Thrombus is
Medium
Risk of Thrombus is Low Administer
Clopidogrel
Alternative Due To Similar
Transition
Avoid thrombi Pursue Risk of Thrombus is
Medium
Risk of Thrombus is Low Administer
Tramadol
Alternative Due To Similar
Transition
Repetition Due To Same
Action
Reduce blood
pressure
Pursue Blood Pressure is High Blood Pressure is
Normal
Administer
Thiazide
Alternative Due To
Inverse Transition
Contradiction Due To
Same Action
Reduce pain Pursue Patient has Pain Patient has no Pain Administer
Ibuprofen
Contradiction Due To
Same Action
Incompatible Drug
External Interaction
Alternative Due To Similar
Transition
Reduce pain Pursue Patient has Pain Patient has no Pain Administer
Tramadol
Alternative Due To Similar
Transition
Repetition Due To
Same Action
Table 6
Cumulative Interactions.
Recommend. T pre Situation post Situation Care Action Interaction Type
Avoid
thrombi
Pursue Risk of Thrombus is
Medium
Risk of Thrombus
is Low
Administer
Aspirin
Alternative Due To Similar
Transition
Avoid
thrombi
Pursue Risk of Thrombus is
Medium
Risk of Thrombus
is Low
Administer
Clopidogrel
Alternative Due To Similar
Transition
Avoid
thrombi
Pursue Risk of Thrombus is
Medium
Risk of Thrombus
is Low
Administer
Tramadol
Alternative Due To Similar
Transition
Reuse of guideline knowledge. The laborious
work of transforming paper-based guidelines into
computer-interpretable guidelines (CIG) is a com-
mon process for all approaches. However, con-
cerning the reuse of guideline knowledge, we have
adopted a different strategy. While the analysed
approaches consider the whole CIG as one piece of
knowledge, we chose to split CIGs into two parts:
One describing the recommendations and one de-
scribing the actions. This choice allows for hav-
ing shareable pieces of knowledge (i.e. actions and
rules). Reusing the recommendations requires a
little bit more work because they need to be du-
plicated from one existing guideline to the other
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Table 7
Comparison to related works.
Wilk[26] Jafarpour[11] Lopez-
Vallverdu[14]
TMR4I Model
Core
Concepts
Actions & Rules
guideline-dependent
Tasks & Constraints
guideline-dependent
Actions &
Rules
guideline-
dependent
TMR + Interactions & Rules
guideline-INdependent
Repre-
sentation
of Rec-
ommen-
dations
Textual
Procedural
Textual
Procedural
Textual
Procedural
Structured
Declarative
Lan-
guage
Workflow & CLP OWL + SWRL Proprietary
Rule-based
Notation
Conceptual: UML + FOL
Implemented: OWL +
SPARQL
Medical
background
knowledge
defined for specific
guideline merges
No No DrugBank
Reuse of
CIG
knowl-
edge
Yes Yes, associating
rules to the original
tasks
Yes, by
reusing the
rules
Yes, duplicating
recommendations, sharing
actions/transitions
Interac-
tions
Identification
Semi-automatic
Pairwise
Manual
Pairwise
Manual
Pairwise
Semi-automatic
Among several guidelines
Type of
Interac-
tions
not applicable identical and
conflicting actions,
reuse of results,
temporal/sequential
aspects
Drug-related
conflicts
Internal: Contradiction,
Alternative and Repetition;
External: Incompatible Drug
and Alternative Drug
Solutions
Identification
Semi-automatic
introduced as CLP
clauses and further
incorporated to
actionable graph.
Manual
Introduced as text
in SWRL
constraints
Manual
Introduced as
standard text
in a Rule
Manual: Introduced as TMR
recommendations
Semi-Automatic: Alternative
drugs retrieved from
external database
Outcome
Verification
Semi-automatic,
limited applicability
Verifiable by the same
approach
Automated by
SWRL rules, limited
applicability
Manual Semi-automatic
Verifiable by the same
approach
Imple-
menta-
tion
Proprietary database
Allow combining
guidelines considering
a patient context
Proprietary
database
Allow executing
together many
pairwise combined
guidelines
Proprietary
database
Allow
combining
many
treatments
Web available database
(Drugbank)
Allow combining two or
more guidelines
and be validated by domain experts. For the other
analysed approaches all reuse of piece of knowledge
requires the validation of domain experts. Another
advantage observed in our approach is that ac-
tions can be modified independently of the guide-
line (under certain conditions). In the future we
intend to better define these conditions and use
them to evaluate when a CIG need to be updated.
Interactions. All approaches provide ways to de-
tect interactions between recommendations. Jafar-
pour’s approach proposes a number of types of
interactions that can be identified. It allows ad-
dressing identical and conflicting actions, as well
as reuse of results (similar effec/result), which are
close to our proposal, besides addressing tempo-
ral/sequential aspects. Lopez-Vallverdu approach
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is meant for identifying drug-related interactions.
Both approaches propose to have one rule to each
potential interaction (based on the instances),
what can lead to a huge number of rules that be-
come complex to maintain up-to-date. In the ap-
proach of Wilk et al. a similar situation is ob-
served, although the rules as pre-defined CLP
clauses allow semi-automatically identification of
conflicts and correspondent mitigation of opera-
tors (types are not defined). However, those ap-
proaches do not address interactions involving
three or more recommendations. In our approach,
we apply guideline-independent rules for automat-
ically identifying some internal and external types
of interactions. These rules can also detect inter-
actions holding between two or more recommen-
dations within two or more guidelines.
Outcome verification. the introduction of new
recommendations requires further verification for
eventual new conflicts that could arise. If all poten-
tial conflicts need to be solved by adding context-
dependent rules, it may lead to a combinatorial
explosion of rules. This, in turn, increases the com-
plexity of detecting conflicting rules; especially if
the verification is done manually by experts. In
particular, Jafarpour defines SWRL rules that al-
low automatically detecting some time/priority-
related conflicts between pairs of introduced con-
straints, but does not address other types of con-
flicts and does not find eventual conflicts with ex-
isting tasks. In our approach, since we introduced
the solutions as recommendation in the same for-
mat as the original ones, the same rules can be
applied for verifying new conflicts (generated by
the outcome of the reasoning engine).
Implementation. All approaches were imple-
mented, however only our approach uses Semantic
Web technology to evaluate the efficacy of the pro-
posed method. The other approaches developed
their own database to evaluate their methods.
The proposed approach is still not mature
enough to be applied to handle the whole com-
plexity of real guidelines. However, since it is a
complex problem, we are applying an incremen-
tal approach to address it. The evaluation of the
work done until now uses (simplified) realistic case
studies to demonstrate the current contribution.
More features will be incrementally added to the
approach and evaluated in more complec scenar-
ios. The proposed prototype will also be incremen-
tally improved for demonstrating the feasibility of
automatic detection of interactions. The potential
end-users of an information system with such fea-
ture can be (i) guideline developers when handling
diseases that commonly happen together or (ii)
physicians in clinical practice setting, if they would
need to combine guidelines (when they were not
previously addressed by the guideline developers).
An extension of this work addressing hierarchies
of Care Action Types (e.g. Administer Aspirin
specializes Administer NSAID) and side effects is
provided in [32]. Future work includes addressing
also sequencing, composition, time and quantities.
Further improvements concerning more detailed
representation for transitions, situation types and
recommendations, besides including goals, evi-
dence and recommendation strength. We plan to
further investigate (i) the use of Semantic Web
Technologies to implement future versions of the
TMR/TMR4I models, as well as (ii) links to other
available databases (e.g. Sider) and terminologies
(e.g. SNOMED-CT). In particular, the use of stan-
dard terminologies mapped to each other (e.g. via
UMLS) would allow combining guidelines anno-
tated with different terminologies. We also intend
to pursue compatibility with existing CIG lan-
guages meant for execution of guidelines and we
position our work as complementary to them.
Finally, this work focus on the clinical knowl-
edge modelling and its applicability for multimor-
bidity issue rather than the process of acquir-
ing/extracting such knowledge. In other words, it
is about which knowledge should be acquired in
order to be able to account for detecting interac-
tions among the recommendations, as well as sug-
gesting some solution. Therefore, the process of ac-
quiring this knowledge from natural language clin-
ical guidelines or other sources is not the focus of
this work.
9. Conclusion
With the ever aging of the population, multi-
morbidity is becoming a huge problem and re-
quire appropriate tools for supporting the physi-
cians to design adapted treatment plans. To this
end, we introduce in this paper TMR4I as a
model for detecting interactions among recom-
mendations within several guidelines using Se-
mantic Web technologies. We demonstrate that
our approach goes beyond state-of-the-art in ad-
V. Zamborlini et al. / Inferring Recommendation Interactions in Clinical Guidelines 27
dressing multimorbidity with respect to some im-
portant features. This is possible by (i) rely-
ing on a more detailed semantics for represent-
ing the recommendations and actions, (ii) defin-
ing guideline-independent rules for detecting in-
teractions and (iii) making the most of Web-based
external knowledge sources that allow to detect
drug-drug interactions and alternative drugs with
few or no human-intervention. Our approach fa-
vor combining several guidelines since it provides
means for (semi) automatically identifying interac-
tions among many recommendations within many
guidelines, and effectively verifying the resultant
merged guideline by reapplying the approach.
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